Orthopedic device market access study in China
The client was targeting n=23 heads of departments (HODs) from Top 50/100 Orthopedic hospitals in China for 60-minute qualitative TDIs.
The sample included HODs from orthopedic, devices/equipment, finance, and procurement - as well as C-suite professionals.
The objective of the study was to understand the economic value drivers for new orthopedic devices in China.
Advanced NSCLC patient journey study in China and Hong Kong
Client was aiming to conduct an study including qualitative IDIs online quantitative interviews.
The method included 8 paired patient and caregiver interviews, 52 HCP interviews, 6 KOL interviews, and 2 pathology interviews in China.
The sample size in Hong Kong was a bit smaller. We completed 3 paired patient and caregiver interviews, 26 HCP interviews and 2 payor interviews.
The objective of the study was to understand the current market landscape and future opportunities for advanced NSCLC treatment. An in-home observation method was used to understand patient journey in-depth.
Vaccines study across APAC
The client was aiming to conduct a large-scale qualitative study (n=30s per country) concerning market entry assessment across APAC countries (China, Japan, Korea, Taiwan, Australia) for vaccines targeting two infectious disease areas.
The objective of the study was to speak with various stakeholders, such as current and ex-payors, HCPs, patients and KOLs about the need for / value of a vaccine.
GPP (generalized pustular psoriasis) -
a designated intractable disease treatment study in Japan
We completed multiple studies concerning GPP treatment and prescribing.
Dermatologist treating GPP were interviewed with a total sample of n=23 across multiple studies.
Successful completion of IgAN physician and patient study in 4 markets
IgAN is another designated intractable disease in Japan and globally is considered a hard target for conducting research.
We were able to secure interviews with 9-10 physicians and 4-6 patients across 4 markets: Japan, Taiwan, South Korea, and China.
Rare Cancer KOL Qualitative Study
The client aiming to conduct n=5 qualitative interviews with KOLs concerning NUT midline carcinoma (a very rare cancer type with limited known data).
We successfully completed the study.